» Authors » Linda J de Wit-van der Veen

Linda J de Wit-van der Veen

Explore the profile of Linda J de Wit-van der Veen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 79
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Hiel B, Aalbersberg E, van den Eertwegh A, Fischer J, Boellaard R, de Vos F, et al.
Clin Nucl Med . 2024 May; 49(8):722-726. PMID: 38768063
Purpose: This prospective study evaluates the biodistribution of 18 F-FLT PET in patients with advanced melanoma before and after treatment with BRAF/MEK inhibitors. Patients And Methods: Eighteen BRAF-positive unresectable stage...
2.
Hoogenkamp D, de Wit-van der Veen L, Huizing D, Tesselaar M, van Leeuwaarde R, Stokkel M, et al.
Curr Oncol Rep . 2024 Apr; 26(5):551-561. PMID: 38598035
Purpose Of Review: To provide insights into the role of peptide receptor radionuclide therapy (PRRT) in patients with advanced neuroendocrine tumors (NET) and an overview of possible strategies to combine...
3.
van der Hiel B, Aalbersberg E, van den Eertwegh A, de Wit-van der Veen L, Stokkel M, Lopez-Yurda M, et al.
Clin Nucl Med . 2023 Dec; 49(2):138-145. PMID: 38113329
Purpose: The aims of this study were to investigate whether (early) PERCIST response monitoring with 18 F-FDG PET/CT is predictive for progression-free survival (PFS) in unresectable stage III or IV...
4.
Aalbersberg E, Geluk-Jonker M, Young-Mylvaganan T, de Wit-van der Veen L, Stokkel M
J Vis Exp . 2019 May; (146). PMID: 31058910
Neuroendocrine tumors are a rare form of cancer that arise from neuroendocrine cells and can be present at almost any location throughout the body. Although heterogeneous in presentation, a common...
5.
Aalbersberg E, Rossi M, de Wit-van der Veen L, Walraven I, van den Heuvel M, Sonke J, et al.
Radiother Oncol . 2019 Apr; 134:30-36. PMID: 31005221
Aims: Pre-hydration is routinely applied to reduce nephrotoxicity in concurrent cisplatin-based chemo-radiotherapy (CCRT). However, pre-hydration may also have systemic effects, potentially leading to lower tumour cisplatin concentrations. We investigated the...
6.
van Brummelen E, Huisman M, de Wit-van der Veen L, Nayak T, Stokkel M, Mulder E, et al.
Oncotarget . 2018 Jun; 9(37):24737-24749. PMID: 29872502
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with abolished IL-2 receptor (IL-2R) α binding. We describe the biodistribution and tumor accumulation of Zr-labeled...
7.
Pouw B, de Wit-van der Veen L, Van Duijnhoven F, Rutgers E, Stokkel M, Olmos R, et al.
Clin Nucl Med . 2015 Nov; 41(5):e216-20. PMID: 26595340
Background: Mammographic screening has led to the identification of more women with nonpalpable breast cancer, many of them to be treated with breast-preserving surgery. To accomplish radical tumor excision, adequate...
8.
Hellingman D, Vidal-Sicart S, de Wit-van der Veen L, Paredes P, Olmos R
Clin Nucl Med . 2015 Jun; 41(1):e39-43. PMID: 26053725
Purpose: Although portable gamma cameras (PGCs) have been helpful to depict sentinel nodes (SNs), sometimes nuclear physicians or surgeons have difficulties to interpret PGC images because of the lack of...
9.
Pouw B, de Wit-van der Veen L, Stokkel M, Olmos R
Clin Nucl Med . 2015 Apr; 40(9):e457-60. PMID: 25899590
Purpose: Freehand single-photon emission computed tomography (SPECT) (fh-SPECT) for optical tracked 3-dimensional radioactivity mapping raises popularity for sentinel node biopsy and other radio-guided procedures. However, the device seems to be...
10.
Pouw B, de Wit-van der Veen L, Stokkel M, Loo C, Vrancken Peeters M, Olmos R
J Surg Oncol . 2014 Sep; 111(2):185-91. PMID: 25195916
Wire-guided localization is the most commonly used technique for intraoperative localization of non-palpable breast cancer. Radioactive seed localization (RSL) is becoming more popular and seems to be a reliable alternative...